Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 10, 2014
Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiationOvidio Hernando-Requejo, Mercedes López, Antonio Cubillo, et al.
BMC Cancer|September 18, 2023
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in EuropeJulien Taieb, Thomas Seufferlein, Michele Reni, et al.
Investigational New Drugs|November 23, 2016
Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumorsLuis Paz-Ares, Martin Forster, Valentina Boni, et al.
BMC Cancer|July 10, 2020
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimensZev A Wainberg, Kynan Feeney, Myung Ah Lee, et al.
Surgical Oncology|November 9, 2017
A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinomaBenedetto Ielpo, Riccardo Caruso, Hipolito Duran, et al.
American Journal of Clinical Oncology|February 13, 2014
Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal CancerAntonio Cubillo, Jesús Rodriguez-Pascual, Fernando López-Ríos, et al.
Case Reports in Oncology|August 15, 2024
Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case ReportMarisa Torres Velasco, Rafael Álvarez Gallego, Paloma Peinado, et al.
International Journal of Cancer|May 15, 2018
Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancerEric Van Cutsem, Manuel Hidalgo, Jean-Luc Canon, et al.
American Journal of Clinical Oncology|December 6, 2012
A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancerAntonio Cubillo, Ovidio Hernando-Requejo, Elena García-García, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
Pageof 6